Delivery included to the United States

Biomarkers for Cancers Responsive to Modulators of HEC1 Activity

Biomarkers for Cancers Responsive to Modulators of HEC1 Activity United States Patent 9976183

Paperback (20 Dec 2020)

Not available for sale

Out of stock

This service is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Publisher's Synopsis

Contemplated compositions and methods are drawn to biomarkers and methods related to treatment of neoplastic disease with Hec1 inhibitor. Gene status and/or expression levels of Hec1(HEC), Rb(RB1), and/or p53 (TP53) may be useful as biomarkers for sensitivity to treatment with a Hec1 inhibitor. In addition, Hec 1 inhibitors may show synergistic effects when used in conjunction with cytotoxic drugs.

Book information

ISBN: 9798583178063
Publisher: Independently Published
Imprint: Independently Published
Pub date:
Language: English
Number of pages: 28
Weight: 91g
Height: 280mm
Width: 216mm
Spine width: 2mm